| What it does | Institutional-grade forex reports for retail traders
| Stock ratings for US stocks based on published research signals
|
|---|
| Stage | Not given
| Startup
|
|---|
| Founded | Not given
| 2025
|
|---|
| Based in | US
| PL
|
|---|
| Pricing model | Paid
| Freemium
|
|---|
| Pricing | Phase I (until November 14, 2026): $99/month for life, 10-business-day free trial, no credit card required. Phase II (November 15 to February 28, 2027): $139/month, rate held while subscription active, 5-business-day free trial with credit card. Phase III (from March 1, 2027): $189/month, rate held
| Free plan with limited access to 200 largest stocks. Paid Tessera plan: $2 for first month, then $29/month, billed monthly. Cancel anytime. 30-day money-back guarantee.
|
|---|
| Key features | - Reports on 7 major currency pairs (EUR/USD, GBP/USD, USD/JPY, USD/CHF, USD/CAD, AUD/USD, NZD/USD)
- Approximately 80-100 reports per month
- Reports delivered by email or Telegram
- Built on CME Group market data translated to spot prices
- Confluence Grade showing institutional context alignment
- Price action analysis with order flow data
- Positioning and interest rate gap analysis
- Reports in English and Spanish
- Zone width approximately 30 pips
- Not a trading signals service
| - Six published research signals averaged into stock ratings
- Free access to ratings on the 200 largest US stocks
- Company financial analysis and sector comparisons
- Stock screening on valuation, profitability, growth and momentum
- Rules-based paper portfolio tracking with simulated trading
- Custom paper portfolios with historical backtesting
- Analyst estimates and DCF valuation tools
- CSV export for custom analysis
- Rating changes tracked weekly by signal
|
|---|
| What makes it different | - Built on CME Group market data instead of free feeds or recycled headlines
- Full reasoning and context provided with each zone, not blind signals
- Institutional-grade market intelligence priced for retail traders
- No-commitment delivery: only reports when real zones are identified, not on forced schedule
| - Connects stock screening with company research and paper portfolio tracking in one workspace
- Ratings based on six published academic research signals, not proprietary black boxes
- Free access to research on largest 200 stocks, no credit card required
- Educational research and ranking signals, explicitly not investment advice
- Affordable paid plan at $2 first month then $29/month with backtesting and full universe access
|
| Community votes | 0 | 0 |
| DR (Domain Rating by Ahrefs) | Not checked yet ● no change since last check | 4 ● no change since last check |
| Trust Flow (Majestic) | 6 | 3 |
| Citation Flow (Majestic) | 11 | 19 |
| Referring domains (Majestic) | 7 | 9 |